The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Condition: Empagliflozin in Cardiorenal Syndrome Type 1 Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Sponsor: Chulalongkorn University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Condition: Heart Failure Interventions: Drug: Finerenone; Drug: Empagliflozin Sponsors: Colorado Prevention Center; Saint Luke's Hospital of Kansas City; Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials